137 related articles for article (PubMed ID: 37925936)
21. Development of Novel PET Probes for Central 2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptors.
Oi N; Tokunaga M; Suzuki M; Nagai Y; Nakatani Y; Yamamoto N; Maeda J; Minamimoto T; Zhang MR; Suhara T; Higuchi M
J Med Chem; 2015 Nov; 58(21):8444-62. PubMed ID: 26469379
[TBL] [Abstract][Full Text] [Related]
22. [Quantification of AMPA receptor densities enables to disclose underlying mechanisms of neuropsychiatric disorders].
Miyazaki T
Nihon Yakurigaku Zasshi; 2022; 157(3):196-199. PubMed ID: 35491118
[TBL] [Abstract][Full Text] [Related]
23. Glutamate Stimulates Local Protein Synthesis in the Axons of Rat Cortical Neurons by Activating α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors and Metabotropic Glutamate Receptors.
Hsu WL; Chung HW; Wu CY; Wu HI; Lee YT; Chen EC; Fang W; Chang YC
J Biol Chem; 2015 Aug; 290(34):20748-20760. PubMed ID: 26134564
[TBL] [Abstract][Full Text] [Related]
24. Development of Thiochroman Dioxide Analogues of Benzothiadiazine Dioxides as New Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors.
Etsè KS; Dorosz J; McLain Christensen K; Thomas JY; Botez Pop I; Goffin E; Colson T; Lestage P; Danober L; Pirotte B; Kastrup JS; Francotte P
ACS Chem Neurosci; 2021 Jul; 12(14):2679-2692. PubMed ID: 34242002
[TBL] [Abstract][Full Text] [Related]
25. Characterization of (
Ahmed H; Wallimann R; Gisler L; Elghazawy NH; Gruber S; Keller C; Liang SH; Sippl W; Haider A; Ametamey SM
ACS Chem Neurosci; 2023 Dec; 14(24):4323-4334. PubMed ID: 38060344
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
Lodge NJ; Li YW; Chin FT; Dischino DD; Zoghbi SS; Deskus JA; Mattson RJ; Imaizumi M; Pieschl R; Molski TF; Fujita M; Dulac H; Zaczek R; Bronson JJ; Macor JE; Innis RB; Pike VW
Nucl Med Biol; 2014 Jul; 41(6):524-35. PubMed ID: 24793011
[TBL] [Abstract][Full Text] [Related]
27. Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury.
Wosik K; Ruffini F; Almazan G; Olivier A; Nalbantoglu J; Antel JP
Brain; 2004 Dec; 127(Pt 12):2636-48. PubMed ID: 15509624
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiological characterization of a novel AMPA receptor potentiator, TAK-137, in rat hippocampal neurons.
Suzuki A; Tajima Y; Kunugi A; Kimura H
Neurosci Lett; 2019 Nov; 712():134488. PubMed ID: 31518676
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of anti-seizure medications on ionotropic glutamate receptors: special focus on AMPA receptor subunits.
Fukushima K; Hatanaka K; Sagane K; Ido K
Epilepsy Res; 2020 Nov; 167():106452. PubMed ID: 32911258
[TBL] [Abstract][Full Text] [Related]
30.
Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and preliminary studies of
Zhang X; Zhang Y; Chen Z; Shao T; Van R; Kumata K; Deng X; Fu H; Yamasaki T; Rong J; Hu K; Hatori A; Xie L; Yu Q; Ye W; Xu H; Sheffler DJ; Cosford NDP; Shao Y; Tang P; Wang L; Zhang MR; Liang SH
Theranostics; 2020; 10(24):11178-11196. PubMed ID: 33042277
[TBL] [Abstract][Full Text] [Related]
32. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
Lauridsen J; Honoré T; Krogsgaard-Larsen P
J Med Chem; 1985 May; 28(5):668-72. PubMed ID: 2859375
[TBL] [Abstract][Full Text] [Related]
33. α-Lipoic Acid Derivatives as Allosteric Modulators for Targeting AMPA-Type Glutamate Receptors' Gating Modules.
Qneibi M; Nassar S; Bdir S; Hidmi A
Cells; 2022 Nov; 11(22):. PubMed ID: 36429036
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Biological Evaluation of Enantiomerically Pure (
Korff M; Chaudhary A; Li Y; Zhou X; Zhao C; Rong J; Chen J; Xiao Z; Elghazawy NH; Sippl W; Davenport AT; Daunais JB; Wang L; Abate C; Ahmed H; Crowe R; Schmidt TJ; Liang SH; Ametamey SM; Wünsch B; Haider A
J Med Chem; 2023 Dec; 66(23):16018-16031. PubMed ID: 37979148
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
36. Negative allosteric modulators of AMPA-preferring receptors inhibit [(3)H]GABA release in rat striatum.
Harsing LG; Csillik-Perczel V; Ling I; Sólyom S
Neurochem Int; 2000 Jul; 37(1):33-45. PubMed ID: 10781843
[TBL] [Abstract][Full Text] [Related]
37. A Review of Molecular Imaging of Glutamate Receptors.
Kim JH; Marton J; Ametamey SM; Cumming P
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081223
[TBL] [Abstract][Full Text] [Related]
38. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
39. The N-terminal domain modulates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor desensitization.
Möykkynen T; Coleman SK; Semenov A; Keinänen K
J Biol Chem; 2014 May; 289(19):13197-205. PubMed ID: 24652293
[TBL] [Abstract][Full Text] [Related]
40. Lead-Induced ERK Activation Is Mediated by GluR2 Non-containing AMPA Receptor in Cortical Neurons.
Ishida K; Kotake Y; Sanoh S; Ohta S
Biol Pharm Bull; 2017; 40(3):303-309. PubMed ID: 28250271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
